Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 5 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cellular therapy in lymphoma.
Hematol Oncol. 2023 Jun 29. doi: 10.1002/hon.3200. Online ahead of print.
Hematol Oncol. 2023.
PMID: 37382086
Review.
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Spanjaart AM, Pennings ERA, Mutsaers PGNJ, van Dorp S, Jak M, van Doesum JA, de Boer JW, Niezink AGH, Kos M, Vermaat JSP, Sijs-Szabo A, van der Poel MWM, Nijhof IS, Kuipers MT, Chamuleau MED, Lugtenburg PJ, Doorduijn JK, Serroukh YIM, Minnema MC, van Meerten T, Kersten MJ; Dutch CAR-T Tumorboard Consortium.
Spanjaart AM, et al. Among authors: pennings era.
Cancers (Basel). 2023 Aug 30;15(17):4334. doi: 10.3390/cancers15174334.
Cancers (Basel). 2023.
PMID: 37686611
Free PMC article.
Item in Clipboard
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy.
de Boer JW, Pennings ERA, Kleinjan A, van Doesum JA, Spanjaart AM, Mutsaers PGNJ, Jak M, van der Poel MWM, Kuipers MT, Adam JA, Diepstra A, Koens L, van Dorp S, Vermaat JSP, Niezink AGH, Kersten MJ, van Meerten T.
de Boer JW, et al. Among authors: pennings era.
Blood Adv. 2023 Nov 14;7(21):6710-6716. doi: 10.1182/bloodadvances.2023010665.
Blood Adv. 2023.
PMID: 37639324
Free PMC article.
No abstract available.
Item in Clipboard
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities.
Spanjaart AM, Pennings ERA, Kos M, Mutsaers PGNJ, Lugtenburg PJ, van Meerten T, van Doesum JA, Minnema MC, Jak M, van Dorp S, Vermaat JSP, van der Poel MWM, van Oijen MGH, Kuipers MT, Nijhof IS, Kersten MJ.
Spanjaart AM, et al. Among authors: pennings era.
JCO Oncol Pract. 2023 Mar;19(3):e407-e416. doi: 10.1200/OP.22.00501. Epub 2022 Dec 12.
JCO Oncol Pract. 2023.
PMID: 36508702
Free PMC article.
Item in Clipboard
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
de Boer JW, Keijzer K, Pennings ERA, van Doesum JA, Spanjaart AM, Jak M, Mutsaers PGNJ, van Dorp S, Vermaat JSP, van der Poel MWM, van Dijk LV, Kersten MJ, Niezink AGH, van Meerten T; Dutch CAR-T Tumorboard Consortium.
de Boer JW, et al. Among authors: pennings era.
Cancers (Basel). 2023 Nov 16;15(22):5443. doi: 10.3390/cancers15225443.
Cancers (Basel). 2023.
PMID: 38001703
Free PMC article.
Item in Clipboard
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.
Pennings ERA, Durmaz M, Visser O, Posthuma EFM, Issa DE, Chamuleau MED, Lugtenburg PJ, Kersten MJ, Dinmohamed AG.
Pennings ERA, et al.
Blood Cancer J. 2024 Jan 4;14(1):3. doi: 10.1038/s41408-023-00970-z.
Blood Cancer J. 2024.
PMID: 38177115
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite